Table 3

The coefficients of determination (r2) for the in vitro rates of CYP-specific enzyme activities versus in vitro rates of nevirapine metabolite formation by characterized human hepatic microsomes in incubations with 25 or 100 μM NVP

Specific Activity3-bNVP Metabolite3-a
2-HydroxyNVP3-HydroxyNVP8-HydroxyNVP12-HydroxyNVP
25 μM100 μM25 μM100 μM25 μM100 μM25 μM100 μM
EROD0.0320.0070.2530.2830.0470.1410.0640.020
CNDM0.0790.0340.3810.4070.1070.2390.1320.061
CH0.0730.1100.2140.268 0.873 0.2060.1820.151
EFCOD0.5920.456 0.944 0.980 0.742 0.848 0.6790.531
MND0.6430.546 0.947 0.988 0.877 0.895 0.7520.623
TMH0.4180.5660.0010.0330.0780.2400.4100.527
MPH0.0020.0060.0450.0000.3260.0000.0100.012
DODM0.0460.1040.0070.0000.0250.0170.0640.100
CZH0.1490.2360.0050.0040.3510.0780.1060.182
TSTH 0.933 0.994 0.3220.5000.126 0.821 0.919 0.978
LAH0.1960.3790.0020.0480.0000.1630.2730.346
  • 3-a Bold numbers indicate the best correlations.

  • 3-b EROD = 7-Ethoxyresorufin-O-deethylase (CYP1A)

  • CNDM = Caffeine N-demethylase (CYP1A2)

  • CH = Coumarin 7-hydroxylase (CYP2A6)

  • EFCOD = furafylline-inhibited 7-ethoxy-4-trifluoromethyl coumarin-O-deethylase (CYP2B6)

  • MND = S-Mephenytoin N-demethylase (CYP2B6)

  • TMH = Tolbutamide methyl-hydroxylase (CYP 2C9)

  • MPH = S-Mephenytoin 4-hydroxylase (CYP2C19)

  • DODM = Dextromethorphan O-demethylase (CYP2D6)

  • CZH = Chlorzoxazone 6-hydroxylase (CYP2E1)

  • TSTH = Testosterone 6β-hydroxylase (CYP3A4)

  • LAH = Lauric acid 12-hydroxylase (CYP4A)

  • n = 10, except for 3-hydroxynevirapine (25 μM), wheren = 9, and 8-hydroxynevirapine (25 μM), wheren = 5